CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes

CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes

Abstract Background Cutaneous squamous cell carcinoma (cSCC) is the second most prevalent form of skin cancer, showing a rapid increasing incidence worldwide. Although most cSCC can be cured by surgery, a sizeable number of cases are diagnosed at advanced stages, with local invasion and distant meta...

Full description

Bibliographic Details
Main Authors: Marika Quadri, Natascia Tiso, Francesco Musmeci, Maria I. Morasso, Stephen R. Brooks, Luca Reggiani Bonetti, Rossana Panini, Roberta Lotti, Alessandra Marconi, Carlo Pincelli, Elisabetta Palazzo
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Cutaneous squamous cell carcinoma
CD271
Trk receptors
3D models
Zebrafish
Online Access:https://doi.org/10.1186/s13046-023-02737-7

Internet

https://doi.org/10.1186/s13046-023-02737-7

Similar Items